Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03292926 · ClinicalTrials.gov registry record · Phase 4
A Novel Analgesia Technique for ACL Reconstruction
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT03292926 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 78 participants.
The verdict
NCT03292926, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) reconstruction.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
- DEVICE Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2017-10-04 |
| Est. Completion | 2020-04-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03292926
The ClinicalTrials.gov registry entry for NCT03292926 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT03292926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03292926 about?
NCT03292926 is a clinical study titled "A Novel Analgesia Technique for ACL Reconstruction". A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) ...
What is the current status of trial NCT03292926?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2017-10-04. Estimated completion is 2020-04-16.
What interventions are being tested in trial NCT03292926?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03292926?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.